metoclopramide has been researched along with Bronchial Diseases in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Bronchial Diseases: Diseases involving the BRONCHI.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The pharyngeal hypophysis from a patient with primary hypothyroidism was hypertrophic, with TSH cell hyperplasia; while that from a patient treated with metoclopramide, a dopamine-receptor-blocking drug, showed PRL cell hyperplasia." | 3.67 | Immunocytochemical evidence for the ability of the human pharyngeal hypophysis to respond to change in endocrine feedback. ( Ciocca, DR; Puy, LA; Stati, AO, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciocca, DR | 1 |
| Puy, LA | 1 |
| Stati, AO | 1 |
1 other study available for metoclopramide and Bronchial Diseases
| Article | Year |
|---|---|
Immunocytochemical evidence for the ability of the human pharyngeal hypophysis to respond to change in endocrine feedback.
Topics: Adenoma; Adolescent; Aged; Bronchial Diseases; Endocrine Glands; Feedback; Female; Histocytochemistr | 1985 |